Abstract
Background and aim
Identification of the esophageal gastric junction (EGJ) is of crucial importance for the consistent detection of Barrett’s esophagus (BE). In Japan, the distal end of the lower esophageal palisade vessels is used to define the EGJ. However, in Western countries, the EGJ is defined as the proximal margin of the gastric folds. In this prospective study, we compared the variation in endoscopic diagnosis of BE using the Japanese criteria (J-criteria) and the Prague C & M criteria (P-criteria) as a landmark of the EGJ.
Methods
A total of 82 patients were enrolled in this study. The patients were referred to the Veterans Affair Palo Alto Health Care System from May 2008 to July 2008. We assessed the recognition rates of the EGJ and the detection rates of endoscopic BE, first using the J-criteria and later using the P-criteria by the American endoscopists.
Results
Identification rate of EGJ was 87.8 % (72/82) using the J-criteria and 97.5 % (80/82) using the P-criteria (P = 0.008). 28.0 % (23/82) of the cases were endoscopically diagnosed as BE using the J-criteria, whereas 17.0 % (14/82) of the cases were diagnosed as BE using the P-criteria (P = 0.049). There was a significant difference in the detection rates between the J-criteria and P-criteria.
Conclusions
We showed the different ratios in the endoscopic detection of BE using the J-criteria and P-criteria. The difference in the prevalence rate of BE in Japan and Western countries can be partly attributed to differences in the endoscopic diagnose of BE.
Similar content being viewed by others
References
Blot WJ, Devesa SS, Kneller RW, Fraumeri JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287–9.
Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993;104:510–3.
Shoji T, Hongo M, Fukudo S. Increasing incident of Barrett’s esophagus and Barrett’s carcinoma in Japan. Gastroenterology. 1999;116:A312 (Abstract).
Kusano C, Gotoda T, Christopher JK, Katai H, Taniguchi H, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol. 2008;23:1662–5.
Hongo M. Review article: Barrett’s oesophagus and carcinoma in Japan. Aliment Pharmacol Ther. 2004;20(suppl 8):50–4.
Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825–31.
Kawano T, Ogiya K, Nakajima Y, Nishikage T, Nagai K, et al. The prevalence of Barrett’s mucosa in Japan. Esophagus. 2006;3:155–64.
Aoki T, Kawaura Y, Kouzu T, et al. Report on Research Committee of Definition on Barrett’s Esophagus (Epithelium) In: Sugimachi K, editor. Reports on Research Committees Japanese Society for Esophageal Diseases. Japanese Society of Esophageal Diseases 2000; p. 20–23 (in Japanese).
Hoshihara Y, Kosuge T, Yamamoto T, Hashimoto M, Hoteya O. Endoscopic diagnosis of Barrett’s esophagus (Japanese with English abstract). Nippon Rinsho. 2005;63:1394–8.
Amano K, Adachi K, Katsube T, Watanabe M, Kinoshita Y. Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly. J Gastroenterol Hepatol. 2001;16:132–6.
Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C and M criteria. Gastroenterology. 2006;131:1392–9.
Sharma P, mcquaid K, Dent J, Fennerty MB, Sampliner R, et al. A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop. Gastroenterology. 2004;127:310–330.
Kusano C, Kaltenbach T, Shimazu T, Soetikno R, Gotoda T. Can Western endoscopists identify the end of the lower esophageal palisade vessels as a landmark of esophagogastric junction? J Gastroenterol. 2009;44:842–6.
Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Loss Angeles classification. Gut. 1999;45:172–80.
Barrett NR. Chronic peptic ulcer of the oesophagus and ‘‘oesophagitis’’. Br J Surg 38:175–182.
de Carvalho CA. Surl’angioarchitecture veineuse de la zone de transition oesophagogastriquw et son interpretation functionnelle. Acta Anat (Basel). 1996; 64:125–162.
Noda T. Angioarchitectural study of esophageal varices. With special reference to variceal rupture. Virchows Arch A Pathol Anast Histopathol.1984;404:381–392.
Amano Y, Ishimura N, Furuta K, Takahashi Y, Chinuki D, et al. Which landmark results in more consistent diagnosis of Barrett’s esophagus, the gastric folds or the palisade vessel ? Gastrointestinal Endosc. 2006;64:206–11.
Kinjo T, Kusano C, Oda I, Gotoda T. Prague C&M and Japanese criteria: shades of Barrett’s esophagus endoscopic diagnosis. J Gastroenterol. 2010;45:1039–44.
Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology. 1999;116:277–85.
Nandurkar S, Talley NJ, Martin CJ, Ng TH, Adams S. Short segment Barrett’s esophagus: prevalence, diagnosis and association. Gut. 1997;40:710–5.
Sampliner RE. Practice Parameters Committee of the American College of Gastroenterology. Up dated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol. 2002;97:1888–95.
American Gastroenterological Association, Spechler SJ, SharmaP, Souza RF, Inadomi JM, et al. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–109.
Liu W, Hahn H, Odze RD, Goyal RK. Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. Am J Gastroenterol. 2009;104:816–24.
Kelty CJ, Gough MD, Van Wyk Q, Stephenson TJ, Ackroyd R. Barrett’s oesophagus: intestinal metaplasia is not essential for cancer risk. Scand J Gastroenterol. 2007;42:1271–4.
Japanese Classification of Esophageal Cancer; 10th ed. The Japan esophageal society. 2008.
Playford RJ. New British Society of Gastroenterology (BSG) guide- lines for the diagnosis and management of Barrett’s oesophagus. Gut. 2006;55:442.
Acknowledgments
The authors thank Dr. Shai Friedland, Tohru Sato, the attending fellows and all of the medical staff in the section of GI endoscopy, Veterans Affairs Palo Alto Health Care System, USA for their cooperation. The authors are also indebted to Dr. Helena Popiel (PhD, Lecturer) and Dr. Edward Barroga (PhD, Associate Professor) of the Department of International Medical Communications of Tokyo Medical University for editing and reviewing the English manuscript.
Ethical Statement
The study reported involved human participants and it meets the ethical principles of the Declaration of Helsinki (WMA 2008).
Conflict of interest
The authors report that there are no disclosures relevant to this publication.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kusano, C., Gotoda, T., Kaltenbach, T. et al. Differences in the endoscopic detection rates of Barrett’s esophagus using the Japanese and Western criteria: a pilot study. Esophagus 13, 25–29 (2016). https://doi.org/10.1007/s10388-015-0483-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10388-015-0483-7